Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease

The SARS-CoV-2 main protease (M(pro)) is one of the molecular targets for drug design. Effective vaccines have been identified as a long-term solution but the rate at which they are being administered is slow in several countries, and mutations of SARS-CoV-2 could render them less effective. Moreove...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadaka, Adewale Oluwaseun, Sibuyi, Nicole Remaliah Samantha, Martin, Darius Riziki, Klein, Ashwil, Madiehe, Abram, Meyer, Mervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430653/
https://www.ncbi.nlm.nih.gov/pubmed/34502340
http://dx.doi.org/10.3390/ijms22179431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430653/
https://www.ncbi.nlm.nih.gov/pubmed/34502340
http://dx.doi.org/10.3390/ijms22179431

Ejemplares similares